ArticleTherapeutic advances in respiratory disease

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease.

Kyriakos Souliotis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.